Find out more about working with immunogenicity as well as what the future may hold for the field in this interview with Joyce Slusser (KCAS).
Find out more about what is important when outsourcing, in this interview with Lee Abberley (GSK).
In this interview, Joao discusses the molecules and products he reviews and how important it is to understand how they affect efficacy and safety in patients.
To kick-start this our special focus on immunogencity, we wanted to hear your thoughts on the topic. Complete our short survey on immunogencity and be the first to receive our informative infographic collated from the survey results.
BioAgilytix (NC, USA) have announced their partnership with Sword Bio (IL, USA), to expand their bioanalytical services to include Sword Bio’s detection platform for immunoassays.
In this interview, Robert Durham gives an overview of the new Gyrolab® xPand from Gyros Protein Technologies, presented at WRIB this year.
Read time: 5:30 mins
In this interview, Arno Kromminga discusses the benefits and challenges associated with current methods, and what he believes the future holds for immunogencity.
Immunogenicity of therapeutic protein products: current considerations for anti-drug antibody assay in Japan
In this review, the authors introduce the current situation regarding the development and immunogenicity assessment of therapeutic protein products in Japan. Then they present their view and recommendations on the ADA assay by considering its unique features.
In this month long feature, we bring you a collection of content focusing on the ‘hot topic’ of immuno-oncology.
LC-MS-based approaches are increasingly used for the quantification of proteins in biological samples. Traditionally, triple…